Cargando…
Hypoxia and glioblastoma therapy
Autores principales: | Yang, Chunzhang, Hong, Christopher S., Zhuang, Zhengping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586094/ https://www.ncbi.nlm.nih.gov/pubmed/26298282 |
Ejemplares similares
-
Application of Peptide Nucleic Acid-based Assays Toward Detection of Somatic Mosaicism
por: Hong, Christopher S, et al.
Publicado: (2016) -
New Developments in the Pathogenesis and Therapeutic Targeting of the IDH1 Mutation in Glioma
por: Dimitrov, Lilia, et al.
Publicado: (2015) -
Somatic mosaicism of EPAS1 mutations in the syndrome of paraganglioma and somatostatinoma associated with polycythemia
por: Yang, Chunzhang, et al.
Publicado: (2015) -
Vorinostat suppresses hypoxia signaling by modulating nuclear translocation of hypoxia inducible factor 1 alpha
por: Zhang, Chao, et al.
Publicado: (2017) -
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
por: Pang, Ying, et al.
Publicado: (2017)